In this piece, we will take a look at ten special situation penny stocks to consider.
Keep Reading →
June 27 - Hedge Funds, News
Operator: Good day and thank you for standing by. Welcome to the Spectrum Pharmaceuticals 4Q 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Keep Reading →
March 24 - News, Transcripts
In this article, we will be taking a look at the 5 best biotech penny stocks to buy now.
Keep Reading →
November 29 - Hedge Funds, News
In this article, we discuss the 5 biotech penny stocks to buy according to Reddit.
Keep Reading →
August 6 - Hedge Funds, News
In this article, we will be looking at the 15 best penny stocks to buy now.
Keep Reading →
July 14 - Hedge Funds, News
In this article, we discuss the 5 best biotech penny stocks to buy now.
Keep Reading →
June 14 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
December 14 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
June 21 - Hedge Funds, News
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Keep Reading →
December 17 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
October 28 - Hedge Funds, News
Hedge funds run by legendary names like George Soros and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Keep Reading →
June 28 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and famous investors to create an extensive database of hedge fund holdings.
Keep Reading →
May 7 - Hedge Funds, News
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable...
Keep Reading →
December 12 - Hedge Funds, News
Paul Singer’s Elliott Management Corp. and Mediapro have discussed the possibility of the U.S.
Keep Reading →
May 22 - Hedge Funds, Insider Trading
In wanting to sell Sears’ assets to his investment vehicle ESL, chief executive Eddie Lampert is tacitly admitting his tenure has been a failure.
Keep Reading →
May 4 - Hedge Funds, Insider Trading
Hedge fund Folger Hill Asset Management is merging with Schonfeld Strategic Advisors and returning capital to certain investors in May, according to an investor letter sent Tuesday...
Keep Reading →
April 11 - Hedge Funds, Insider Trading
What happened: Shares of Spectrum Pharmaceuticals, Inc.
Keep Reading →
March 7 - Market Movers, News
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...
Keep Reading →
December 12 - Hedge Funds, News
On September 14, 2016, the FDA’s Oncologic Drugs Advisory Committee met to evaluate and discuss a drug called apaziquone.
Keep Reading →
September 28 - News, Stock Analysis
When things go well in biotech, it can be a great ride.
Keep Reading →
September 16 - News, Stock Analysis
Next month, an advisory panel will get together to discuss, and rule upon, Spectrum Pharmaceuticals, Inc.
Keep Reading →
August 23 - News, Stock Analysis
It was a rough third quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during the quarter.
Keep Reading →
November 22 - Hedge Funds, News
In two separate filings with the U.S.
Keep Reading →
September 3 - Hedge Funds, News
Steven Boyd's Armistice Capital has further increased its activist stake in Spectrum Pharmaceuticals, Inc.
Keep Reading →
June 4 - Hedge Funds, News
Millennium Management, Spectrum Pharmaceuticals: Israel Englander and his hedge fund company Millennium Management now hold over 3.2 million shares of Spectrum Pharmaceuticals...
Keep Reading →
October 21 - Hedge Funds, News
Today, let's look at Tudor Investment, founded in 1980 by Paul Tudor Jones, and featuring the flagship Tudor BVI fund.
Keep Reading →
September 12 - Hedge Funds, News
Now, according to many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten age.
Keep Reading →
September 6 - News
Now, according to many market players, hedge funds are viewed as bloated, outdated investment tools of a forgotten age.
Keep Reading →
September 3 - News
If you were to ask many traders, hedge funds are seen as useless, outdated investment vehicles of a period lost to current times.
Keep Reading →
August 30 - News
In the financial world, there are many indicators shareholders can use to analyze Mr. Market. A pair of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 30 - News
For the last several years, certain stocks have remained cheap as the overwhelming presence of short sellers have made it more difficult for shares to break out.
Keep Reading →
July 12 - News
For the last five years, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) CEO Rajesh Shrotriya has always insisted that Spectrum Pharmaceuticals, Inc.
Keep Reading →
July 8 - News
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) got crushed with a downgrade from Credit Suisse that led to a 6.3% loss on Monday.
Keep Reading →
June 25 - News
How can you double your investment literally overnight? Buy stocks of the right biotech companies.
Keep Reading →
June 13 - News
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) was in 12 hedge funds' portfolio at the end of the first quarter of 2013.
Keep Reading →
June 6 - News
Is Idenix Pharmaceuticals Inc (NASDAQ:IDIX) an excellent stock to buy now? Investors who are in the know are taking a bearish view.
Keep Reading →
June 3 - News
In today’s marketplace, there are tons of metrics shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading sentiment.
Keep Reading →
June 3 - News
What's the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest.
Keep Reading →
May 13 - News
As I noted seven weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
April 17 - News
Up until last week, Navistar International Corp (NYSE:NAV) traded with a one-year loss of 42%.
Keep Reading →
April 16 - News
As I noted six weeks ago, cancer statistics are both staggering and disappointing.
Keep Reading →
April 10 - News
Although the Nasdaq Composite is the only major U.S. index that's nowhere near its all-time high, it still turned in an impressive gain of 8.2% for the quarter.
Keep Reading →
April 7 - News
Is Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) a buy here? Prominent investors are taking a bullish view.
Keep Reading →
April 3 - News
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) up 28% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Keep Reading →
March 17 - News
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
Keep Reading →
March 14 - News
Shaw is known as a math wizard and a quantitative investing pioneer. His firm is reportedly extremely selective, hiring less than 1% of applicants -- and Amazon.com, Inc.
Keep Reading →
March 14 - Hedge Funds
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is hurting today after dialing back guidance for the year. Apparently the increased production by Sagent Pharmaceuticals Inc.
Keep Reading →
March 13 - News
After six straight record highs for the Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI), the market finally looks like it's running out of steam.
Keep Reading →
March 13 - News
Yesterday, I published an article titled, “When Being Short Backfires!” So it's only appropriate to look at the other side of the trade.
Keep Reading →
March 13 - News
Just 10 days ago, I examined the bear thesis on Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) as, amazingly, over half of its float was sold short.
Keep Reading →
March 13 - News